Post-treatment PSA =<0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques - 5-year tumor control and morbidity

Authors: Critz F.A.; Williams W.H.; Holladay C.T.; Levinson A.K.; Benton J.B.; Holladay D.A.; Schnell F.J.; Maxa L.S.; Shrake P.D.

Source: Urology, Volume 54, Number 6, December 1999 , pp. 968-971(4)

Publisher: Elsevier

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0090-4295(99)00346-5

Affiliations: 1: aRadiotherapy Clinics of Georgia, Decatur, Georgia, USA

Publication date: 1999-12-01

• In this: publication
• By this: publisher
• In this Subject: Urology
• By this author: Critz F.A. ;  Williams W.H. ;  Holladay C.T. ;  Levinson A.K. ;  Benton J.B. ;  Holladay D.A. ;  Schnell F.J. ;  Maxa L.S. ;  Shrake P.D.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers